Stefano Duga

Prof. Dr. Stefano Duga


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in JACC
Verified
Journal Article
Closed access
AKAmit V. Khera
Amit V. Khera
HWHong-Hee Won
Hong-Hee Won
GPGina M. Peloso
Gina M. Peloso
KLKim S. Lawson
Kim S. Lawson
TBTraci M. Bartz
Traci M. Bartz
SKSekar Kathiresan
Sekar Kathiresan

10 December 2014 in Nature
Verified
Journal Article
Open access
PDF file
RDRon Do
Ron Do
NSNathan O. Stitziel
Nathan O. Stitziel
HWHong-Hee Won
Hong-Hee Won
AJAnders Berg Jørgensen
Anders Berg Jørgensen
SDStefano Duga
Stefano Duga
SKSekar Kathiresan
Sekar Kathiresan
Exome sequence analysis of nearly 10,000 people was carried out to identify alleles associated with early-onset myocardial infarction; mutations in low-density lipoprotein receptor (LDLR) or apolipoprotein A-V (APOA5) were associated with disease risk, identifying the key roles of low-density lipoprotein cholesterol and metabolism of triglyceride-rich lipoproteins. Sekar Kathiresan and colleagues use exome sequencing of nearly 10,000 people to probe the contribution of multiple rare mutations within a gene to risk for myocardial infarction at a population level. They find that mutations in low-density lipoprotein receptor (LDLR) or apolipoprotein A-V (APOA5) are associated with disease risk. When compared with non-carriers, LDLR mutation carriers had higher plasma levels of LDL cholesterol, whereas APOA5 mutation carriers had higher plasma levels of triglycerides. As well as confirming that APOA5 is a myocardial infarction gene, this work informs the design and conduct of rare-variant association studies for complex diseases. Myocardial infarction (MI), a leading cause of death around the world, displays a complex pattern of inheritance1,2. When MI occurs early in life, genetic inheritance is a major component to risk1. Previously, rare mutations in low-density lipoprotein (LDL) genes have been shown to contribute to MI risk in individual families3,4,5,6,7,8, whereas common variants at more than 45 loci have been associated with MI risk in the population9,10,11,12,13,14,15. Here we evaluate how rare mutations contribute to early-onset MI risk in the population. We sequenced the protein-coding regions of 9,793 genomes from patients with MI at an early age (≤50 years in males and ≤60 years in females) along with MI-free controls. We identified two genes in which rare coding-sequence mutations were more frequent in MI cases versus controls at exome-wide significance. At low-density lipoprotein receptor (LDLR), carriers of rare non-synonymous mutations were at 4.2-fold increased risk for MI; carriers of null alleles at LDLR were at even higher risk (13-fold difference). Approximately 2% of early MI cases harbour a rare, damaging mutation in LDLR; this estimate is similar to one made more than 40 years ago using an analysis of total cholesterol16. Among controls, about 1 in 217 carried an LDLR coding-sequence mutation and had plasma LDL cholesterol > 190 mg dl−1. At apolipoprotein A-V (APOA5), carriers of rare non-synonymous mutations were at 2.2-fold increased risk for MI. When compared with non-carriers, LDLR mutation carriers had higher plasma LDL cholesterol, whereas APOA5 mutation carriers had higher plasma triglycerides. Recent evidence has connected MI risk with coding-sequence mutations at two genes functionally related to APOA5, namely lipoprotein lipase15,17 and apolipoprotein C-III (refs 18, 19). Combined, these observations suggest that, as well as LDL cholesterol, disordered metabolism of triglyceride-rich lipoproteins contributes to MI risk.

1 September 2004 in Blood
Verified
Journal Article
Closed access
PDF file
PMPier Mannucci
Pier Mannucci
SDStefano Duga
Stefano Duga
FPFlora Peyvandi
Flora Peyvandi
Deficiencies of coagulation factors other than factor VIII and factor IX that cause bleeding disorders are inherited as autosomal recessive traits and are rare, with prevalences in the general population varying between 1 in 500 000 and 1 in 2 million for the homozygous forms. As a consequence of the rarity of these deficiencies, the type and severity of bleeding symptoms, the underlying molecular defects, and the actual management of bleeding episodes are not as well established as for hemophilia A and B. We investigated more than 1000 patients with recessively inherited coagulation disorders from Italy and Iran, a country with a high rate of recessive diseases due to the custom of consanguineous marriages. Based upon this experience, this article reviews the genetic basis, prevalent clinical manifestations, and management of these disorders. The steps and actions necessary to improve the condition of these often neglected patients are outlined.

3 October 2016 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
Roberto CiliaRoberto Cilia
Roberto Cilia
STSara Tunesi
Sara Tunesi
GMGiorgio Marotta
Giorgio Marotta
ECEmanuele Cereda
Emanuele Cereda
Chiara SiriChiara Siri
Chiara Siri
SGStefano Goldwurm
Stefano Goldwurm

1 October 2014 in Neuron
Verified
Journal Article
Closed access
BSBradley N. Smith
Bradley N. Smith
NTNicola Ticozzi
Nicola Ticozzi
CFClaudia Fallini
Claudia Fallini
AGAthina Soragia Gkazi
Athina Soragia Gkazi
STSimon Topp
Simon Topp
CBCinzia Bertolin
Cinzia Bertolin

5 June 2020 in Aging
Verified
Journal Article
Open access
Rosanna AsseltaRosanna Asselta
Rosanna Asselta
EPElvezia Maria Paraboschi
Elvezia Maria Paraboschi
Alberto MantovaniAlberto Mantovani
Alberto Mantovani
SDStefano Duga
Stefano Duga
As the outbreak of coronavirus disease 2019 (COVID-19) progresses, prognostic markers for early identification of high-risk individuals are an urgent medical need. Italy has one of the highest numbers of SARS-CoV-2-related deaths and one of the highest mortality rates. Worldwide, a more severe course of COVID-19 is associated with older age, comorbidities, and male sex. Hence, we searched for possible genetic components of COVID-19 severity among Italians by looking at expression levels and variants in ACE2 and TMPRSS2 genes, crucial for viral infection.